ArticleInfection and drug resistance2025
Appendiceal Perforation and Abdominal Wall Infection Caused by Invasive Mucormycosis in a Child with Acute Leukemia.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal mucormycosis is one of the most difficult forms of the disease to diagnose due to its lack of specific clinical features. It is extremely rare to observe gastrointestinal mucormycosis in pediatric acute leukemia patients undergoing chemotherapy. In this report, we describe a case of a child with acute leukemia who developed invasive mucormycosis, leading to appendiceal perforation and abdominal wall infection. Initially, surgical intervention was delayed due to concerns over exacerbating bone marrow suppression, which ultimately resulted in the progression of the intra-abdominal infection. However, after thorough debridement of the abdominal wall infection and treatment with liposomal amphotericin B, the patient gradually recovered. This case highlights the importance of early and complete debridement of abdominal wall infections and intra-abdominal abscesses to prevent the further spread of mucormycosis, shorten the course of the disease, and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.